Clinical Trial Update: PET/CT Imaging for Radiation Dosimetry, Plasma Pharmacokinetics, Biodistribution, Safety and Tolerability and Diagnostic Performance of BAY86-7548 in Patients With Prostate Cancer and Healthy Volunteers [Phase 1]

View source ↗

Summary

Phase 1 clinical trial evaluating BAY86-7548 for PET/CT imaging in prostate cancer patients and healthy volunteers, assessing radiation dosimetry, plasma pharma…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Drugs mentioned

• BAY86-7548

Snippet

Sponsor: Life Molecular Imaging SA | Conditions: Diagnostic Imaging | Phase 1 | Status: COMPLETED